Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.40M | 2.59M | 3.75M | 3.00M | 2.74M |
| Total Depreciation and Amortization | 1.16M | 1.16M | 1.02M | 934.10K | 857.90K |
| Total Amortization of Deferred Charges | 50.40K | 25.50K | 103.80K | 103.80K | 103.80K |
| Total Other Non-Cash Items | 715.60K | 727.70K | -1.55M | -1.42M | -1.45M |
| Change in Net Operating Assets | -550.30K | -1.31M | -1.78M | -509.50K | -1.55M |
| Cash from Operations | 2.78M | 3.19M | 1.55M | 2.11M | 704.50K |
| Capital Expenditure | -1.32M | -1.20M | -1.12M | -748.10K | -682.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -197.80K | -197.80K | -197.80K | -- | -- |
| Cash from Investing | -1.52M | -1.40M | -1.32M | -748.10K | -682.50K |
| Total Debt Issued | -- | -- | 33.10K | 33.10K | 1.32M |
| Total Debt Repaid | -522.30K | -522.40K | -522.40K | -293.30K | -294.40K |
| Issuance of Common Stock | 443.40K | 363.80K | 357.30K | 368.10K | 97.80K |
| Repurchase of Common Stock | -1.38M | -925.30K | -798.70K | -802.20K | -807.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -- | -- | -- |
| Cash from Financing | -1.06M | -794.80K | -685.20K | -515.50K | 234.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 193.70K | 997.90K | -459.40K | 843.80K | 256.60K |
